| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |